Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer

Prostate cancer (PCa) is the most common noncutaneous cancer diagnosis and the second leading cause of cancer-related deaths among men in the United States. Effective treatment modalities for advanced metastatic PCa are limited. Immunotherapeutic strategies based on T cells and antibodies represent...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiessling, Andrea, Wehner, Rebekka, Füssel, Susanne, Bachmann, Michael, Wirth, Manfred P., Schmitz, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712678/
https://www.ncbi.nlm.nih.gov/pubmed/24213236
http://dx.doi.org/10.3390/cancers4010193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712678/
https://www.ncbi.nlm.nih.gov/pubmed/24213236
http://dx.doi.org/10.3390/cancers4010193

Ejemplares similares